The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Type 2 Diabetes Mellitus
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
200 cases will be included and divided into four groups with 50 cases in each group
200 cases will be included and divided into four groups with 50 cases in each group
Tracking Information
- NCT #
- NCT04217291
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Mu Chinese PLA General Hospital
Get Well Soon